Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditions. (2020)

First Author: George CN
Attributed to:  the roleDefining of IL-1B in breast cancer bone metastasis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jbo.2020.100317

PubMed Identifier: 32995253

Publication URI: http://europepmc.org/abstract/MED/32995253

Type: Journal Article/Review

Volume: 25

Parent Publication: Journal of bone oncology

ISSN: 2212-1366